Drug Trial Radar · NCT05761795
Efficacy of IVMED-85 on Pediatric Myopia
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
144
Planned (sponsor's estimate)
Start
Feb 2027
Primary completion
Feb 2029
Study completion Jun 2029
Sponsor
- Lead sponsor
- iVeena Delivery Systems, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 9, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 5 years, up to 10 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of a 12-month course of IVMED-85 ophthalmic solution on the treatment of pediatric myopia. The main aims are: * Assess the efficacy of a 12-month treatment of IVMED-85 in slowing myopia progression in pediatrics * Assess the safety of a 12-month treatment of IVMED-85 Participants will use eyedrops twice a day for 12 months. Researchers will compare IVMED 85 (2 doses) to a placebo.
Conditions
- Myopia, Progressive
Interventions
IVMED-85 ophthalmic solution, Low DoseDrug
Eye drop
IVMED-85 ophthalmic solution, High doseDrug
Eye drop
PlaceboDrug
Eye drop
Primary outcomes
What the sponsor says the trial is designed to measure.
- Refractive error change from baseline at Month 12Time frame: Baseline compared to month 12
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.